Related Experiment Videos
[Macular translocation after photodynamic therapy: a case report]
A Mirshahi1, F Schreyger, H Baatz
1Augenzentrum Recklinghausen, Recklinghausen. mirshahi@web.de
Klinische Monatsblatter Fur Augenheilkunde
|July 22, 2005
Summary
Macular translocation surgery can restore vision in exudative age-related macular degeneration (ARMD) patients with persistent vision loss after photodynamic therapy (PDT). This surgical option offers improved visual acuity and high patient satisfaction.
Area of Science:
- Ophthalmology
- Retinal Surgery
Background:
- Exudative age-related macular degeneration (ARMD) is a leading cause of vision loss.
- Photodynamic therapy (PDT) is a common, non-invasive treatment for exudative ARMD.
- Surgical macular translocation is an alternative treatment option.
Observation:
- A case study involving a 79-year-old patient with exudative ARMD and juxtafoveal choroidal neovascularisation (CNV) unresponsive to PDT.
- The patient underwent surgical macular translocation with 360 degrees retinotomy due to continued visual decline post-PDT.
- Intraoperative findings revealed increased adhesion between the CNV and the retina, a potential complication not typically seen in patients without prior PDT.
Findings:
- Surgical macular translocation resulted in a significant improvement in visual acuity, from 0.1 to 0.4 (six Snellen lines) nine months post-surgery.
- No recurrence of CNV was observed.
- The patient reported high satisfaction with the surgical outcome.
Implications:
- Macular translocation with 360 degrees retinotomy may be a viable treatment for exudative ARMD cases that do not respond to PDT.
- Increased intraoperative adhesion of CNV to the retina post-PDT necessitates careful surgical planning to minimize retinal damage.
- Patient counseling regarding potential complications is crucial before considering this surgical intervention.